financetom
Business
financetom
/
Business
/
Vaxcyte Insider Sold Shares Worth $353,699, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Vaxcyte Insider Sold Shares Worth $353,699, According to a Recent SEC Filing
Mar 7, 2025 2:19 PM

04:54 PM EST, 03/07/2025 (MT Newswires) -- Mikhail Eydelman, Senior Vice President, Generics, General COunsel and Corporate Secretary, on March 05, 2025, sold 5,000 shares in Vaxcyte ( PCVX ) for $353,699. Following the Form 4 filing with the SEC, Eydelman has control over a total of 41,620 common shares of the company, with 41,620 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1649094/000164909425000045/xslF345X05/wk-form4_1741383777.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Why Is Eightco Holdings Stock Rocketing Today?
Why Is Eightco Holdings Stock Rocketing Today?
Sep 25, 2024
Eightco Holdings Inc. ( OCTO ) shares are trading higher after the company provided an update to shareholders highlighting its 2024 achievements and 2025 initiatives. In 2024, the company significantly improved its balance sheet, eliminating $5.4 million in convertible notes and increasing shareholder equity by $23 million. Additionally, 5.8 million dilutive shares related to warrants and convertible securities were canceled,...
Flutter Bets Big On US And Global Expansion: $21B Revenue Goal And $5B Buyback In Sight
Flutter Bets Big On US And Global Expansion: $21B Revenue Goal And $5B Buyback In Sight
Sep 25, 2024
Online sports betting and iGaming company Flutter Entertainment plc ( FLUT ) shares are trading higher after the company announced medium-term guidance for 2027 and authorized a share repurchase program. The company targets revenue of around $21 billion in 2027, representing a compound annual growth rate (CAGR) of 14%, based on the midpoint of U.S. and Rest of World (ROW)...
Looking At Oracle's Recent Unusual Options Activity
Looking At Oracle's Recent Unusual Options Activity
Sep 25, 2024
Deep-pocketed investors have adopted a bullish approach towards Oracle , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in ORCL usually suggests something big is about to happen. We gleaned this information from our observations today...
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
Emergent BioSolutions Confirms Orders Worth $400M Related To Smallpox, Mpox Vaccines
Sep 25, 2024
On Wednesday, Emergent BioSolutions Inc. ( EBS ) said it secured approximately $400 million in orders in 2024 and 2025 associated with its vaccinia, smallpox, and mpox product portfolio. What Happened: The order includes the previously disclosed U.S. government contract modification to procure ACAM2000 (Smallpox and Mpox (Vaccinia) Vaccine, Live), as well as CNJ-016 [Vaccinia Immune Globulin Intravenous (Human)] (VIGIV) contract options exercised in 2023 and 2024....
Copyright 2023-2026 - www.financetom.com All Rights Reserved